LaurenBKruppMD

Neurology • New York, NY

Neuroimmunology/Multiple Sclerosis

Professor, NYU Grossman School of Medicine Director, NYU Langone MS Comprehensive Care Center

Join to view full profile

Dr. Krupp is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Krupp's full profile

Already have an account?

Office
240 E 38th St
# 18
New York, NY 10016
Phone+1 646-501-7500

Fax+1 646-754-9593

Summary

I direct the MS division at NYU Langone, across LI, Brooklyn, NYC, and lead clinical research in MS across the age span with primarily investigator initiated studies. My interests focus on pediatric MS and other pediatric CNS demyelinating disorders and issues related to fatigue, cognitive function. More recent research addresses the effects of childhood adversity in pediatric and adult onset MS.

Education & Training

National Institutes of Health Clinical CenterFellowship, Neuroimmunology & Multiple Sclerosis, 1985 - 1987
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 1982 - 1985
Westchester Medical CenterInternship, Internal Medicine, 1981 - 1982
Albert Einstein College of MedicineClass of 1981

Certifications & Licensure

NY State Medical License 1984 - 2026
MD State Medical License 1987 - 1988
American Board of Psychiatry and Neurology Neurology

Clinical Trials

Improving Memory in Patients With Multiple Sclerosis Start of enrollment: 1999 Sep 01
Withdrawn
Phase 3
Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis Start of enrollment: 2011 Oct 01
Completed
Vitamin D Supplementation in Multiple Sclerosis Start of enrollment: 2012 Mar 01
Completed
Phase 3
Computerized Exercise Training for Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya Start of enrollment: 2013 Aug 01
Completed
Not Applicable
Computerized Cognitive Exercise Training Treatment for Adults With Multiple Sclerosis Start of enrollment: 2013 Sep 01
Unknown status
Not Applicable
A Teleheath tDCS Approach to Decrease Cannabis Use Start of enrollment: 2022 Sep 13
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Acute eculizumab treatment in a pediatric patient with AQP4-IgG+ NMOSD.
Ria H Soni, Mekka Garcia, Eunhye Oak, Eliana J Applbaum, Logi Rajagopalan
Multiple Sclerosis. 2025-01-22
Distinct plasma lipids predict axonal injury and multiple sclerosis activity.
Vinicius A Schoeps, Pavan Bhargava, Akash Virupakshaiah, Dimitrios Christos Ladakis, Carson Moseley
Journal of Neurology, Neurosurgery, and Psychiatry. 2025-01-16
Association of Social Determinants of Health With Brain MRI Outcomes in Individuals With Pediatric Onset Multiple Sclerosis.
Ruby Ross, Kimberly A O'Neill, Rebecca A Betensky, Thibo Billiet, Rachel Kenney
Neurology. 2024-12-24

Journal Articles

Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis
Jerry S Wolinsky, Lauren Krupp, Emmanuelle Waubant, Tanuja Chitnis, Brenda Banwell, Kevin Rostasy, The New England Journal of Medicine

Press Mentions

New MS Treatment Shows Promise in TrialAugust 25th, 2022
The Pros and Cons of Remote Learning for MS KidsSeptember 21st, 2020
Asthma Drug May Slow Brain Damage in Multiple Sclerosis PatientsNovember 3rd, 2017
Join now to see all

Professional Memberships

American Academy of Neurology - AAN
Member